2026 NPPES data Medical Oncology Physician NPI 1639258379 MD
Verify on CMS →

MATHEW CHERIAN, MD

Medical Oncology Physician in OKLAHOMA CITY, Oklahoma. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
233
Medicare Part D claims · 73 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
95.311/100
▲ 12 pts above national avg 83.1 · [object Object]

What the federal data shows

MATHEW CHERIAN, MD reported a CMS MIPS final score of 95.311/100 — above the 83.1 national average — and filed 233 Medicare Part D claims in 2023.

95.311/100
MIPS score · +12 vs avg
233
Part D claims, 2023
73%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MATHEW CHERIAN, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

95 Top 21% higher than 79% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MATHEW CHERIAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MATHEW CHERIAN, MD?

High performer (top quartile)

NPI registry status

Active

Issued 11/03/2006

NPI 1639258379

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

233 66% vs specialty avg

2023 prescription claims

Specialty avg: 689

MIPS final score

95.311/100 12.211000000000013% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Oklahoma

How Medical Oncology Physician compares to other specialties among Oklahoma providers

Oklahoma providers

Medical Oncology Physician share within Oklahoma

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Oklahoma

Medicare quality performance — MIPS

MATHEW CHERIAN, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average

High performer (top quartile)
MIPS Final Score
95.311/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Medical Oncology Physician) — 95.311/100 vs national avg 83.1

0%100%National avg83%95.3%
MIPS final score (Medical Oncology Physician) — 95.311/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATHEW CHERIAN, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 800 NE 10TH ST STE 3010, OKLAHOMA CITY, OK, 73104, with a listed phone of (405) 271-8778. NPI 1639258379 was issued on 11/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CHERIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 233 prescription claims written by this provider, covering 73 Medicare beneficiaries and totaling roughly $826K in drug spend, split 27% brand-name and 73% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.311/100 for the 2023 performance year (Quality 76.5856), compared with the national average of 83.1.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

800 NE 10TH ST STE 3010
OKLAHOMA CITY, OK 73104

Provider Details

NPI 1639258379
Specialty Medical Oncology Physician
Credentials MD
Gender Male
NPI Issued 11/03/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

95.311
Final Score
Avg: 83.1
76.5856
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where MATHEW CHERIAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

OU HEALTH PARTNERS INC
OKLAHOMA CITY, OK

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Above average

MATHEW CHERIAN, MD — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 233 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

233
Total Claims
$826K
Total Drug Cost
73
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
431
Total Day Supply
12,170
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$819K
Generic Drug Cost
$7K

Patient Demographics

Average Patient Age
70.9 years
Avg HCC Risk Score
1.80
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MATHEW CHERIAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ibrance
Palbociclib
32
Alendronate Sodium
27
Letrozole
24
Anastrozole
22
Kisqali
Ribociclib Succinate
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How MATHEW CHERIAN, MD fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

MATHEW CHERIAN, MD's 233 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in Oklahoma

Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as CHERIAN.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATHEW CHERIAN, MD's specialty?
MATHEW CHERIAN, MD specializes in Medical Oncology Physician and practices in OKLAHOMA CITY, Oklahoma. Credentials: MD.
How much does MATHEW CHERIAN, MD prescribe under Medicare Part D?
In 2023, MATHEW CHERIAN, MD wrote 233 Medicare Part D claims totaling $826K in drug costs for 73 beneficiaries.
What is MATHEW CHERIAN, MD's Medicare quality score?
MATHEW CHERIAN, MD has a CMS MIPS Final Score of 95.311/100 (Quality: 76.5856). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MATHEW CHERIAN, MD located?
MATHEW CHERIAN, MD is located at 800 NE 10TH ST STE 3010, OKLAHOMA CITY, OK, 73104. Phone: (405) 271-8778.
What is MATHEW CHERIAN, MD's NPI number?
MATHEW CHERIAN, MD's National Provider Identifier (NPI) is 1639258379, issued on 11/03/2006.
Does MATHEW CHERIAN, MD prescribe more brand-name or generic drugs?
MATHEW CHERIAN, MD's prescribing is 27% brand-name and 73% generic drugs by claim count, with $819K in brand drug costs.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does MATHEW CHERIAN, MD prescribe most often?
Based on 2023 Medicare Part D data, MATHEW CHERIAN, MD's most frequently prescribed drugs include Ibrance, Alendronate Sodium, Letrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATHEW CHERIAN, MD accept Medicare?
MATHEW CHERIAN, MD appears in CMS Medicare data with 233 Part D claims and 73 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATHEW CHERIAN, MD's credentials?
MATHEW CHERIAN, MD's NPI is 1639258379 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology